Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Mild cognitive impairment represents early-stage Alzheimer disease.

Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L.

Arch Neurol. 2001 Mar;58(3):397-405.

PMID:
11255443
2.

Brain electrical activity (quantitative EEG and bit-mapping neurocognitive CNV components), psychometrics and clinical findings in presenile subjects with initial mild cognitive decline or probable Alzheimer-type dementia.

Zappoli R, Versari A, Paganini M, Arnetoli G, Muscas GC, Gangemi PF, Arneodo MG, Poggiolini D, Zappoli F, Battaglia A.

Ital J Neurol Sci. 1995 Sep;16(6):341-76. Review.

PMID:
8626214
3.

Mild cognitive impairment--an early stage of Alzheimer's disease?

Almkvist O, Basun H, B├Ąckman L, Herlitz A, Lannfelt L, Small B, Viitanen M, Wahlund LO, Winblad B.

J Neural Transm Suppl. 1998;54:21-9. Review.

PMID:
9850912
4.

[Current topics about mild cognitive impairment (MCI)].

Yamamoto Y.

Seishin Shinkeigaku Zasshi. 2011;113(6):584-92. Review. Japanese.

PMID:
21815470
5.

[Conversion from MCI (Mild Cognitive Impairment) to Alzheimer's disease: diagnostic options and predictors].

Defranceso M, Schocke M, Messner HJ, Deisenhammer EA, Hinterhuber H, Marksteiner J, Weiss EM.

Neuropsychiatr. 2010;24(2):88-98. Review. German.

PMID:
20605004
6.

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.

Morris JC, Price JL.

J Mol Neurosci. 2001 Oct;17(2):101-18. Review.

PMID:
11816784
7.

[Concept and clinical presentation of mild cognitive impairment].

Hanyu H.

Brain Nerve. 2010 Jul;62(7):719-25. Review. Japanese.

PMID:
20675876
8.

L-deprenyl in the treatment of mild dementia of the Alzheimer type: results of a 15-month trial.

Burke WJ, Roccaforte WH, Wengel SP, Bayer BL, Ranno AE, Willcockson NK.

J Am Geriatr Soc. 1993 Nov;41(11):1219-25. Review.

PMID:
8227897
9.

[Clinical feature of dementia of the Alzheimer type].

Sasaki H.

Rinsho Byori. 1996 Mar;44(3):207-12. Review. Japanese.

PMID:
8857162
10.

Origins, controversies and recent developments of the MCI construct.

Gainotti G.

Curr Alzheimer Res. 2010 May;7(3):271-9. Review.

PMID:
19860723
11.

Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer's and other dementing processes.

Reisberg B, Franssen EH, Hasan SM, Monteiro I, Boksay I, Souren LE, Kenowsky S, Auer SR, Elahi S, Kluger A.

Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 3:28-36. Review.

PMID:
10654097
12.

Cognitive impairment in elderly who are not yet demented.

Adair JC, Williamson DJ, Knoefel JE.

Compr Ther. 1999 Aug-Oct;25(8-10):390-6. Review.

PMID:
10520440
13.

Modeling the time-course of Alzheimer dementia.

Ashford JW, Schmitt FA.

Curr Psychiatry Rep. 2001 Feb;3(1):20-8. Review.

PMID:
11177755
14.

Neuropathologic alterations in mild cognitive impairment: a review.

Markesbery WR.

J Alzheimers Dis. 2010;19(1):221-8. doi: 10.3233/JAD-2010-1220. Review.

15.
16.

Update on dementia of the Alzheimer type.

Martin RL.

Hosp Community Psychiatry. 1989 Jun;40(6):593-604. Review.

PMID:
2661399
17.

Visuospatial memory in healthy elderly, AD and MCI: a review.

Iachini I, Iavarone A, Senese VP, Ruotolo F, Ruggiero G.

Curr Aging Sci. 2009 Mar;2(1):43-59. Review.

PMID:
20021398
18.

Redox Proteomics of Oxidatively Modified Brain Proteins in Mild Cognitive Impairment.

Reed TT, Sultana R, Butterfield DA.

In: Alzate O, editor. Neuroproteomics. Boca Raton (FL): CRC Press/Taylor & Francis; 2010. Chapter 10.

19.

Neuropsychology--dementia and affective disorders.

Robbins TW, Elliott R, Sahakian BJ.

Br Med Bull. 1996 Jul;52(3):627-43. Review.

PMID:
8949262
20.

Risk factors for dementia in people with down syndrome: issues in assessment and diagnosis.

Bush A, Beail N.

Am J Ment Retard. 2004 Mar;109(2):83-97. Review.

PMID:
15000668

Supplemental Content

Support Center